Connect with us

CBD News

Organigram Enters Into Agreement for Accesses to 60,000kg of CBD Hemp

Elison Grey



Organigram Enters Into Agreement for Accesses to 60,000kg of CBD Hemp
- Ad -

Orgnigram Holdings, a licensed CBD producer, recently issued a press release announcing that it has entered into an advanced payment and purchase agreement with 70354 N.B. Inc, also known as 1812 Hemp. The agreement gives Organigram Holdings the purchase of pre-funded hemp at a size of 60,000 kg. The hemp is to be harvested in 2019 and extracted into isolate CBD.

The purchase agreement allows Organigram to receive access to the hemp flower supply, which according to the press release, contains a significant amount of high levels of CBD, compared to other cultivators approved by Health Canada.

Greg Engel, the CEO of Organigram, shared in the press release,

“Access to a large, consistent volume of CBD-producing hemp has become increasingly important as Canadians express their demand for CBD-rich products for use in both recreational and medical capacities.”

He continued, “We’ve heard the call for CBD in the market and this agreement positions Organigram to meet that demand.”

Elison Grey is one of our up and coming researchers who has a Bachelor’s Degree in Literature and Humanities, as well as being a Licensed Clinical Massage Therapist. She finds comfort in writing about overall health and wellness, diet and nutrition, natural medicine and alternative therapy methods.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.